Healthcare Triangle, Inc. entered into a Separation and Distribution Agreement with its wholly-owned subsidiary Teyame AI Holdings, Inc., to spin off Teyame from the parent company. The transaction involves distributing a minority interest of Teyame common stock pro rata to Healthcare Triangle shareholders, while Healthcare Triangle retains majority ownership. Teyame will operate as a separate public company listed on Nasdaq after filing a Form 10 registration statement. The distribution is expected to be taxable under U.S. federal income tax laws. Healthcare Triangle remains jointly liable for unpaid acquisition consideration related to Teyame's Spanish subsidiaries and has entered into a Transition Services Agreement to provide interim administrative, legal, and IT support. This company operates in the healthcare technology sector.

Healthcare Triangle issued 12,546,540 shares of common stock on July 28, 2026, to satisfy obligations from two previously shareholder-approved transactions. The company delivered 9,718,373 shares to entities directed by Teyame AI LLC for the acquisition closing and issued 2,828,167 shares under a Securities Exchange Agreement with SecureKloud Technologies Ltd. These issuances increased total common stock outstanding to 14,644,322 shares. The transaction supports compliance with Nasdaq’s new $5 million Market Value of Listed Securities standard, resulting in an approximate market value of $23,870,244 based on a July 28 closing price of $1.63 per share. Healthcare Triangle provides digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations.

At its virtual annual meeting on July 17, 2026, Healthcare Triangle, Inc. shareholders approved several significant proposals. Key approvals included an amendment to the 2020 Stock Incentive Plan to allow automatic annual share increases, the issuance of 2,828,167 shares under a settlement agreement with SecureKloud Technologies Ltd., and the issuance of up to 11,869,397 shares related to the Teyame Transaction. Shareholders also authorized potential common stock issuances exceeding the exchange cap under an ELOC Purchase Agreement with Hudson Global Ventures, LLC, and issuances underlying OID Senior Secured Convertible Debentures. The meeting resulted in the election of four directors and the ratification of SRCO Professional Corporation as the independent auditor. Healthcare Triangle, Inc. is a healthcare technology company.

Healthcare Triangle, Inc. entered into a Securities Exchange Agreement with SecureKloud Technologies Ltd. to settle debt and make-whole amounts via the issuance of 2,828,167 common stock shares. Additionally, the company amended a Share Purchase Agreement to provide for $12,000,000 in restricted common stock and preferred stock issuances. The company also filed a Certificate of Designations for Series C Convertible Preferred Stock, designating 23,000 shares with a $1,000 stated value. Healthcare Triangle, Inc. provides healthcare data interoperability and AI-driven analytics solutions for the healthcare industry.

Healthcare Triangle, Inc. completed a private placement of 15% original issue discount senior convertible promissory notes totaling $4.235 million for gross proceeds of approximately $3.6 million, maturing December 12, 2026. Additionally, the company entered into an Equity Purchase Agreement with Hudson Global Ventures, LLC for an aggregate purchase price of up to $50,000,000 over a 36-month commitment period. Healthcare Triangle, Inc. provides healthcare data management and interoperability solutions.